Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Sarah Prinsloo

M.D. Anderson Cancer Center

Related
6 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score9%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score9%

Anurag K Singh

Roswell Park Cancer Institute

Related
8 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

Related
9 trials

Shared therapeutic areas:

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Kerri Winters-Stone

OHSU Knight Cancer Institute

Related
8 trials

Shared therapeutic areas:

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

David Hui

M.D. Anderson Cancer Center

Related
9 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score9%

Lorenzo Cohen

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score9%

Heinz-Josef Lenz, MD

University of Southern California

Related
13 trials

Shared therapeutic areas:

Symptomatic COVID-19 Infection Laboratory-Confirmed

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Adenoviridae Infections
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05101213Phase 1PrincipalInvestigator

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Adenovirus InfectionBK Virus InfectionCytomegaloviral Infection+4 more
Terminated

All 1 trials loaded